Physician profile
Alan D Brook
NPI 1316938863
$15,734.75
in general payments reported to CMS, 2019-2025
48 companies · $3,400 in 2025
The $3,400 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,755 · 2020: $1,972 · 2021: $1,370 · 2022: $1,275 · 2023: $2,317 · 2024: $2,646 · 2025: $3,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,280 · Education: $82.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,279.74 |
| Education | $82.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,050.55 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $3,050.39 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $846.69 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $799.36 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $551.77 | 2019-2025 | Dupixent |
| Genzyme Corporation | $543.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $540.55 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $524.70 | 2019-2023 | Uptravi, Opsumit |
| Stryker Corporation | $457.70 | 2021-2025 | Evolve Proline, Broadway 8 |
| Jazz Pharmaceuticals INC. | $453.71 | 2019-2024 | |
| Insmed, INC. | $449.39 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $371.77 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $361.22 | 2024-2025 | |
| Philips North America LLC | $330.29 | 2019-2025 | Encore, Vest Therapy Und, (8874) Incourage |
| United Therapeutics Corporation | $324.95 | 2019-2024 | Tyvaso |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $322.41 | 2019-2025 | Smartvest |
| Genentech USA, INC. | $312.15 | 2019-2025 | Xolair |
| Merck Sharp & Dohme LLC | $284.74 | 2021-2025 | Zerbaxa, Recarbrio, Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $271.71 | 2020-2025 | Glassia |
| Pfizer INC. | $202.94 | 2019-2025 | |
| Amgen INC. | $191.63 | 2022-2024 | Tezspire |
| Imperative Care, INC | $176.77 | 2025 | Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $174.99 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.24 | 2019-2022 | |
| Axsome Therapeutics, INC. | $139.91 | 2023-2025 | Sunosi |
| Sunovion Pharmaceuticals INC. | $123.33 | 2019-2020 | |
| Boston Scientific Corporation | $101.92 | 2024 | Intracept |
| Verona Pharma, INC. | $66.51 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $54.90 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $53.81 | 2024-2025 | Lumryz |
| Abbvie INC. | $43.62 | 2023-2024 | Teflaro |
| Resmed Corp | $42.94 | 2021-2023 | |
| Apria Healthcare LLC | $33.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.23 | 2019-2021 | |
| Shionogi INC | $31.78 | 2022 | |
| Azurity Pharmaceuticals, INC. | $31.16 | 2025 | Alvesco |
| Pulmonx Corporation | $29.81 | 2021-2022 | |
| Tactile Systems Technology INC | $23.38 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.16 | 2020 | |
| Lilly USA, LLC | $21.49 | 2025 | Zepbound |
| Baxter Healthcare | $20.81 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Veran Medical Technologies, INC. | $18.47 | 2021 | |
| Shire North American Group INC | $17.93 | 2019 | |
| Phadia US INC. | $16.68 | 2023 | Immunocap |
| E.R. Squibb & Sons, L.L.C. | $16.55 | 2024 | Eliquis |
| Vifor Pharma, INC. | $15.02 | 2024 | Veltassa |
| Advanced Respiratory, INC | $14.62 | 2019 | |
| Gilead Sciences, INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Brook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.